Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Kollagen Typ XVIII, alpha 1

Das COL18A1-Gen kodiert ein Kollagen, welches ähnlich dem Kollagen IV aufgebaut ist und ebenso wie dieses in den Basalmembranen vorkommt. Mutationen führen zum autosomal rezessiven Knobloch-Syndrom und können die klinische Ausprägung von Glaukomen beeinflussen.

Gentests:

Forschung Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Modifikatoren der Glaukomausprägung
COL15A1
COL18A1
Knobloch-Syndrome 1
COL18A1

Referenzen:

1.

Menzel O et al. (2004) Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin.

external link
2.

Marneros AG et al. (2003) Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome.

external link
3.

Sudhakar A et al. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

external link
4.

Suzuki OT et al. (2002) Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome.

external link
5.

Iughetti P et al. (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.

external link
6.

Karumanchi SA et al. (2001) Cell surface glypicans are low-affinity endostatin receptors.

external link
7.

Saarela J et al. (1998) Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts.

external link
8.

O'Reilly MS et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

external link
9.

Rehn M et al. (1996) Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters.

external link
10.

Oh SP et al. (1994) Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21.

external link
11.

Rehn M et al. (1994) Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen.

external link
12.

Oh SP et al. (1994) Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins.

external link
13.

O'Reilly MS et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

external link
14.

Sertié AL et al. (2000) Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome).

external link
15.

Czeizel AE et al. (1992) The second report of Knobloch syndrome.

external link
16.

Aldahmesh MA et al. (2013) No evidence for locus heterogeneity in Knobloch syndrome.

external link
17.

Joyce S et al. (2010) Locus heterogeneity and Knobloch syndrome.

external link
18.

Mahajan VB et al. (2010) Collagen XVIII mutation in Knobloch syndrome with acute lymphoblastic leukemia.

external link
19.

Paisán-Ruiz C et al. (2009) Homozygosity mapping through whole genome analysis identifies a COL18A1 mutation in an Indian family presenting with an autosomal recessive neurological disorder.

external link
20.

Khaliq S et al. (2007) Mapping of a novel type III variant of Knobloch syndrome (KNO3) to chromosome 17q11.2.

external link
21.

Shi H et al. (2007) Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.

external link
22.

Keren B et al. (2007) CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene.

external link
23.

Suzuki OT et al. (2005) How pathogenic is the p.D104N/endostatin polymorphic allele of COL18A1 in Knobloch syndrome?

external link
24.

Utriainen A et al. (2004) Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line.

external link
25.

Najmabadi H et al. (2011) Deep sequencing reveals 50 novel genes for recessive cognitive disorders.

external link
26.

OMIM.ORG article

Omim 120328 external link
27.

Orphanet article

Orphanet ID 120702 external link
28.

NCBI article

NCBI 80781 external link
29.

Wikipedia Artikel

Wikipedia DE (COL18A1) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz